|Bid||126.09 x 1000|
|Ask||126.19 x 800|
|Day's Range||123.82 - 127.27|
|52 Week Range||58.38 - 151.97|
|Beta (5Y Monthly)||1.40|
|PE Ratio (TTM)||12.68|
|Earnings Date||Jan 26, 2021 - Feb 01, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Feb 28, 2020|
|1y Target Est||154.48|
At this time, for opening remarks and introductions, I would like to turn the call over to Vice President of Investor Relations Mr. Mark Kimbrough. With me this morning is our CEO, Sam Hazen; our CFO Bill Rutherfor; along with our CMO, Dr. Jon Perlin.
HCA Healthcare (NYSE: HCA) is no exception. While shares of the large hospital operator have rebounded significantly from the lows earlier this year, HCA stock remains in negative territory year to date. HCA announced its third-quarter results before the market opened on Monday, and although there was some good news, investors were disappointed overall.